Pharmacologic modulation of Fgfr2 signaling could be used to support alveolar health during acute injuries like these, helping sustain AT2 cells as a virus or toxin destroys them6–8, and perhaps similarly in chronic diseases such as COPD/emphysema and pulmonary fibrosis57. Here, FGFR2 is linked to chronic obstructive pulmonary disease.